“…However, adjunct therapy with 5-FU may be associated with an increase of vision-threatening complications, such as bleb-related endophthalmitis or hypotony maculopathy [31,32]. Since there is no exact dosage recommendation to date, two treatment modalities are currently used in the clinical setting: single intraoperative application of 5-FU [3,24,33] and postoperative subconjunctival injections of 5-FU [1,2,8,16,20,21,26,27]. Large fluctuations in the frequency of injections and absolute doses of 5-FU can be observed in the literature.…”